Sabadell Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,200
Closed -$871K 127
2022
Q2
$871K Hold
5,200
0.18% 111
2022
Q1
$1.32M Buy
5,200
+550
+12% +$138K 0.23% 91
2021
Q4
$1.18M Buy
4,650
+463
+11% +$113K 0.19% 96
2021
Q3
$1.02M Buy
4,187
+1,718
+70% +$420K 0.18% 105
2021
Q2
$510K Buy
+2,469
New +$503K 0.09% 142

Other funds holding HCA

Sabadell Asset Management's HCA Position: Q3 2022 in Review

Sabadell Asset Management sold out of HCA Healthcare (HCA) in Q3 2022, closing a stake of 5,200 shares — an estimated $871K sold.

Sabadell Asset Management first reported a position in HCA in Q2 2021 and held it in 5 quarters. The position peaked at $1.32M in Q1 2022. 867 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • Sabadell Asset Management reported no remaining HCA Healthcare position as of Q3 2022 after selling out during the quarter.
  • Sabadell Asset Management sold 5,200 HCA Healthcare shares in Q3 2022, an estimated $871K.
  • Sabadell Asset Management first reported a position in HCA Healthcare in Q2 2021 and held it in 5 quarters.
  • Sabadell Asset Management's HCA Healthcare position peaked at $1.32M in Q1 2022.
  • 867 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Sabadell Asset Management's 13F filing for Q3 2022, filed 23 Jan 2024.